Blog

Krystal Biotech KRYS reported fourth-quarter 2025 earnings per share (EPS) of $1.70, which surpassed the Zacks Consensus Estimate of $1.62. The reported EPS was up from $1.52 in the year-ago

Kenvue Inc. KVUE posted solid fourth-quarter results, wherein the top and bottom lines surpassed the Zacks Consensus Estimate. Also, both metrics increased year over year. Organic growth was driven

Shares of Aris Mining Corporation ARMN have been showing some decent gains of late, rising 56.8% in the past three months. The gold producer has outperformed the industry’s and the S&P 500

Citigroup Inc.’s C CEO Jane Fraser continues to advance the company’s multi-year strategy to streamline operations and focus on its core businesses. Since announcing plans in April 2021 to exit

Ciena Corporation CIEN is witnessing accelerating demand across its optical networking portfolio, driven by AI-led network expansion and rising data traffic from cloud and service provider

Central Garden & Pet Company CENT announced that its board of directors increased its share repurchase authorization, signaling a commitment to enhancing shareholder value. The company is now

Halozyme Therapeutics HALO reported fourth-quarter 2025 adjusted loss of 24 cents per share against the Zacks Consensus Estimate of earnings of $2.15. The company had reported adjusted earnings of

The Goldman Sachs Group, Inc.’s GS Asset & Wealth Management (AWM) division is increasingly becoming a core pillar of the firm’s growth strategy, with 2025 results underscoring a steady shift toward

Investors in Alarm.com Holdings, Inc. ALRM need to pay close attention to the stock based on moves in the options market lately. That is because the March 20, 2026 $25 Call had some of the highest

Investors in First BanCorp. FBP need to pay close attention to the stock based on moves in the options market lately. That is because the March 20, 2026 $15 Put had some of the highest implied

Republic Services, Inc. RSG reported mixed fourth-quarter 2025 results. Earnings surpassed the Zacks Consensus Estimate, while revenues missed the same.

RSG’s earnings per share (EPS) of $1.76 beat

The Zacks Investment Management industry faces pressure from rising technology and artificial intelligence (AI)-related expenses, which are likely to weigh on near-term profitability despite

Sonic Automotive (SAH) reported $3.87 billion in revenue for the quarter ended December 2025, representing a year-over-year decline of 0.6%. EPS of $1.52 for the same period compares to $1.51 a year

For the quarter ended December 2025, Wingstop (WING) reported revenue of $175.69 million, up 8.6% over the same period last year. EPS came in at $1.00, compared to $0.88 in the year-ago quarter.

The

Who cares about the Magnificent 7 stocks when there are so many others that are outperforming those? This week there will be several hundred earnings reports including those from popular companies

As we work through the “back-9” of Q4 earnings season, we give way to prominent economic prints this holiday-shortened trading week. Particularly the latest Personal Consumption Expenditures (PCE)

Glaukos Corporation GKOS reported fourth-quarter 2025 adjusted loss of 28 cents per share, which missed the Zacks Consensus Estimate of a loss of 22 cents by 0.06%. The figure improved from the

Samsara Inc. IOT shares have plunged 57.1% in the past year, underperforming the Zacks Internet - Software industry’s 20.1% decline and the Zacks Computer and Technology sector’s return of 18.1%.

HudBay Minerals HBM is set to report fourth-quarter 2025 results on Feb. 20, before market open. HBM is expected to post a solid year-over-year improvement in earnings.

The bottom-line estimate is

U.S. equities ended modestly higher yesterday, reversing early-session weakness as sentiment improved throughout the day. Stocks came under pressure early on after concerns that advances in

Mercury General Corporation MCY reported fourth-quarter 2025 operating income of $3.66 per share, which beat the Zacks Consensus Estimate by 43%. The bottom line surged 31.7% year over year.

Total

Interparfums, Inc. IPAR is likely to register a bottom-line decrease when it reports fourth-quarter 2025 earnings on Feb. 24. The consensus mark for earnings has moved up 5 cents in the past 30 days

OPKO Health, Inc. OPK is well-poised for growth in the coming quarters, supported by the potential of RAYALDEE. The optimism surrounding the stock is backed by RAYALDEE’s performance and strategic